Sonus Pharma (SNUS) ? Opinions Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sonus Pharma (SNUS) ? Opinions

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David S. who wrote (261)	3/13/1998 5:26:00 PM
From: Mr. Giller	Read Replies (2) of 384

Does anyone know how long the company will take to re-analyze and re- submit the Echogen data? I spoke with IR today and was told nothing of any value. They are still working on the reanalysis of the data and then don't know if/when the FDA will have the final word on it. It seems to me that reanalyzing data after a poorly designed study is just like trying to swim in the desert. On the one hand, SNUS should hire some real scientists and at least on statistician; on the other hand FDA should get a life. If the drug increases the sharpnes of ultrasound and makes it a better tool, and it is actually safe (no people dying from it) then what the hell is the big deal??? I appreciate any comments and feedback! Mr. Giller

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next